Coronary Artery Bypass Grafting
Conditions
Interventions
Liposomal bupivacaine LSGB group (Group L):Group L was injected with 0.665% bupivacaine liposomes
Ropivacaine LSGB group (Group R):Group R was injected with 0.25% ropivacaine
Sponsors
The First Affiliated Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Surgical type: Elective coronary artery bypass grafting (without stopping); 2. Age: 45-75 years old, gender not limited; 3. New York College of Cardiology (NYHA) cardiac function classification II or III, left ventricular ejection fraction (LVEF) > 50%; 4. Be capable of mastering the research procedures and the application of various scales, possess the ability to communicate efficiently with follow-up personnel, clearly understand the specific contents of the informed consent form, and make a commitment to voluntarily participate in the research. Both patients and their families voluntarily sign the informed consent document
Exclusion criteria
Exclusion criteria: 1. Refuse to participate; 2. Local anesthetics, coagulant function abnormality, infection, wound puncture in immune function inhibition; 3. Serious psychological disorders can't cooperate with SGB, neck dissection is unusual, stellate ganglion block failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative analgesia score; | — |
Secondary
| Measure | Time frame |
|---|---|
| sleep quality;Anxiety tendency;Postoperative recovery status;Perioperative hemodynamic indicators and myocardial marker indicators;Perioperative myocardial marker indicators; | — |
Countries
China
Contacts
Public ContactYu Chen
The First Affiliated Hospital of Nanjing Medical University
Outcome results
None listed